NEW YORK, Nov. 26, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE_Market_Update_Nov_26 jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2832807/NYSE_Market_Update_Nov_26.mp4’, image: ‘https://mma.prnasia.com/media2/2832807/NYSE_Market_Update_Nov_26.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Ashley Mastronardi delivers the pre-market update on November 26th

The Dow extended its winning streak to three days on Tuesday, jumping over 650 points on optimism for another rate cut. AI enthusiasm lifted the S&P 500 nearly 1%, while Alphabet hit a record high amid reports of AI chip talks with Meta. Despite recent gains, the S&P 500 is down about 1.1% for November, and the Dow has slipped roughly 1%. Markets close Thursday for Thanksgiving and reopen Friday for a shortened session. Santa rings the NYSE opening bell as Macy’s celebrates its 99th Thanksgiving Day Parade, featuring iconic balloons, floats, and live performances.

Opening BellMacy’s (NYSE: M) celebrates the 99th Macy’s Thanksgiving Day Parade

Closing BellSalvation Army NY kicks off the Red Kettle season

Click here to download the NYSE TV App

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

BRENTWOOD, Tenn., Aug. 27, 2024 /PRNewswire/ — Currax Pharmaceuticals LLC ("Currax") today announced…

Xposure Marks 10 Years of Visual Storytelling with Stellar Global Artists

SHARJAH, UAE, Nov. 24, 2025 /PRNewswire/ — Xposure’s International Photography and Film…

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ — Innovent Biologics, Inc.…